Abstract
Abdominal tissue, serum, and bile samples were obtained from 37 patients given a single, 2-g intravenous infusion of aztreonam immediately prior to an elective abdominal operation. Samples were obtained at 0 to 6 h after dosing. Mean concentrations in tissues and fluids and specimen/serum rations are reported. Levels in tissue and bile exceeded the reported MICs for 90% of most members of the family Enterobacteriaceae for up to 6 h.
Full text
PDF


Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Aronoff S. C., Klinger J. D. In vitro activities of aztreonam, piperacillin, and ticarcillin combined with amikacin against amikacin-resistant Pseudomonas aeruginosa and P. cepacia isolates from children with cystic fibrosis. Antimicrob Agents Chemother. 1984 Feb;25(2):279–280. doi: 10.1128/aac.25.2.279. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Buesing M. A., Jorgensen J. H. In vitro activity of aztreonam in combination with newer beta-lactams and amikacin against multiply resistant gram-negative bacilli. Antimicrob Agents Chemother. 1984 Feb;25(2):283–285. doi: 10.1128/aac.25.2.283. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Daschner F. D., Metz B., Spillner G., Buzello W., Schlosser V. Concentrations of cefamandole and cefsulodin in serum, heart valves, subcutaneous tissue, and muscle of patients undergoing open-heart surgery. J Infect Dis. 1980 Aug;142(2):290–290. doi: 10.1093/infdis/142.2.290. [DOI] [PubMed] [Google Scholar]
- Janicke D. M., Cafarell R. F., Parker S. W., Apicella M. A., Jusko W. J. Pharmacokinetics of aztreonam in patients with gram-negative infections. Antimicrob Agents Chemother. 1985 Jan;27(1):16–20. doi: 10.1128/aac.27.1.16. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Madsen P. O., Dhruv R., Friedhoff L. T. Aztreonam concentrations in human prostatic tissue. Antimicrob Agents Chemother. 1984 Jul;26(1):20–21. doi: 10.1128/aac.26.1.20. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Martinez O. V., Levi J. U., Devlin R. G. Biliary excretion of aztreonam in patients with biliary tract disease. Antimicrob Agents Chemother. 1984 Mar;25(3):358–361. doi: 10.1128/aac.25.3.358. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nagar H., Berger S. A. The excretion of antibiotics by the biliary tract. Surg Gynecol Obstet. 1984 Jun;158(6):601–607. [PubMed] [Google Scholar]
- Ng W. W., Chau P. Y., Leung Y. K., Livermore D. M. In vitro activities of Ro 17-2301 and aztreonam compared with those of other new beta-lactam antibiotics against clinical isolates of Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1985 May;27(5):872–873. doi: 10.1128/aac.27.5.872. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pilkiewicz F. G., Remsburg B. J., Fisher S. M., Sykes R. B. High-pressure liquid chromatographic analysis of aztreonam in sera and urine. Antimicrob Agents Chemother. 1983 Jun;23(6):852–856. doi: 10.1128/aac.23.6.852. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Soriano F., Ponte M. C. Comparative activities of aztreonam and cefotaxime against Escherichia coli and Bacteroides spp. in pure and mixed cultures. Antimicrob Agents Chemother. 1984 Jul;26(1):39–41. doi: 10.1128/aac.26.1.39. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Swabb E. A., Sugerman A. A., Platt T. B., Pilkiewicz F. G., Frantz M. Single-dose pharmacokinetics of the monobactam azthreonam (SQ 26,776) in healthy subjects. Antimicrob Agents Chemother. 1982 Jun;21(6):944–949. doi: 10.1128/aac.21.6.944. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sykes R. B., Bonner D. P., Bush K., Georgopapadakou N. H. Azthreonam (SQ 26,776), a synthetic monobactam specifically active against aerobic gram-negative bacteria. Antimicrob Agents Chemother. 1982 Jan;21(1):85–92. doi: 10.1128/aac.21.1.85. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Van Laethem Y., Husson M., Klastersky J. Serum bactericidal activity of aztreonam, cefoperazone, and amikacin, alone or in combination, against Escherichia coli, Klebsiella pneumoniae, Serratia marcescens, and Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1984 Aug;26(2):224–227. doi: 10.1128/aac.26.2.224. [DOI] [PMC free article] [PubMed] [Google Scholar]
